Roche's Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech's programmable T cell-based therapies platform. Genentech is providing ...
There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline of ...
Foundational Concepts in Programming Industrial Robots. Before you can get a robot to do anything useful, you need to understand how it works and the math behind its movements. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results